Science as a public enterprise: the case for open data

被引：70

作者：

Boulton, Geoffrey ^{[1
]}

Rawlins, Michael ^{[2
]}

Vallance, Patrick ^{[3
]}

Walport, Mark ^{[4
]}

机构：

[1] Univ Edinburgh, Grant Inst, Edinburgh EH9 3JW, Midlothian, Scotland

[2] Natl Inst Hlth & Clin Excellence, London, England

[3] GlaxoSmithKline Inc, London, England

[4] Wellcome Trust Res Labs, London, England

来源：

LANCET | 2011年 / 377卷 / 9778期

关键词：

TRIALS; BIAS;

D O I：

10.1016/S0140-6736(11)60647-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1633 / 1635

页数：3

共 12 条

[1]

[Anonymous], BMJ

[2]

[Anonymous], 2010, BBC NEWS 0419

[3]

[Anonymous], CLIMATE FILES

[4]

Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1

[5]

Dickersin K, 1997, AIDS EDUC PREV, V9, P15

[6]

*HUM GEN PROJ, 1997, POL REL HUM GEN SEQ

[7] Data on demand [J].

Kleiner, Kurt .

NATURE CLIMATE CHANGE, 2011, 1 (01) :10-12

[8] Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and Presentation [J].

Rising, Kristin ;

Bacchetti, Peter ;

Bero, Lisa .

PLOS MEDICINE, 2008, 5 (11) :1561-1570

[9]

*ROYAL SOC, 2011, SCI PUBL ENT OP SCI

[10]

Russell M., 2010, The Independent Climate Change E-Mails Reviews

← 1 2 →